Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.

Is There Room for SERMs or SARMs as Alternative Therapies for Adult Male Hypogonadism?

Open access

Abstract

Hypogonadotropic hypogonadism (HH) can be sustained by organic or functional alterations of the hypothalamic-pituitary-testicular axis. Functional HH is related to systemic alterations, such as obesity or chronic inflammatory diseases, but could contribute to a negative course of the illness. For such situation, according to results obtained in infertile women, the administration of selective estrogen receptor modulators (SERMs) has been proposed in males too, with positive results on both metabolic and sexual function. This class of medications increases gonadotropin levels via antagonism to the estrogenic receptor; similar biological effects are also exerted by aromatase inhibitors (AIs), despite different mechanism of action. After a brief review of trials regarding SERMs and AIs use in male HH, we describe the structure and function of the androgen receptor (AR) as a basis for clinical research about compounds able to bind to AR, in order to obtain specific effects (SARMs). The tissue selectivity and different metabolic fate in comparison to testosterone can potentiate anabolic versus androgenic effects; therefore, they might be a valid alternative to testosterone replacement therapy avoiding the negative effects of testosterone (i.e., on prostate, liver, and hematopoiesis). Trials are still at an early phase of investigation and, at the moment, the application seems to be more useful for chronic disease with catabolic status while the validation as replacement for hypogonadism requires further studies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1155/2020/9649838

Cites

68 of 68 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Testosterone (left) is converted by 5α-reductase into 5α-dihydrotestosterone (DHT) (right) in a NADPH-dependent redox reaction.
Figure 1 Testosterone (left) is converted by 5α-reductase into 5α-dihydrotestosterone (DHT) (right) in a NADPH-dependent redox reaction.CC BY · PubMed Central
Figure 2 Illustration of the AR signalling pathway. When A enters into the cell, it is converted into the more potent DHT by 5α-reductase and binds to the ligand-binding pocket of AR forming AR-A and AR-DHT complexes, respectively. Consequently, the AR-A or AR-DHT is translocated into the nucleus with help of other proteins to form the AR-dimer (or AR-DHT dimer, not shown) that is able to bind the ARE region in DNA to regulate the expression of downstream genes thus initiating the transcription of specific protein that exert the androgen effect.
Figure 2 Illustration of the AR signalling pathway. When A enters into the cell, it is converted into the more potent DHT by 5α-reductase and binds to the ligand-binding pocket of AR forming AR-A and AR-DHT complexes, respectively. Consequently, the AR-A or AR-DHT is translocated into the nucleus with help of other proteins to form the AR-dimer (or AR-DHT dimer, not shown) that is able to bind the ARE region in DNA to regulate the expression of downstream genes thus initiating the transcription of specific protein that exert the androgen effect.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 more claim about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 68 references

Research works printed but not linked: 7

  1. 2019, Journal of Andrology, 12, 258
  2. 10.1210/mend.9.2.7776971 · doi:10.1210/mend.9.2.7776971 · Paper page
  3. 10.1210/jcem.84.10.6122 · DOI · Paper page
  4. 10.1210/jcem.84.8.588510.1210/jc.84.8.2647 · doi:10.1210/jcem.84.8.588510.1210/jc.84.8.2647
  5. 10.1210/jcem.83.9.507910.1210/jc.83.9.3155 · doi:10.1210/jcem.83.9.507910.1210/jc.83.9.3155
  6. 10.1210/jcem.86.1.712610.1210/jc.86.1.192 · doi:10.1210/jcem.86.1.712610.1210/jc.86.1.192
  7. 2002, Journal of Musculoskeletal and Neuronal Interactions, 2, 222

Cited by

See all 16

Metadata

Authors
Giagulli, V. A., Silvestrini, A., Bruno, C., Triggiani, V., Mordente, A., & Mancini, A.
Affiliations
  • University of Bari Aldo Moro (IT)
  • Università Cattolica del Sacro Cuore (IT)
Corresponding author
  • Silvestrini, Andrea
  • Mancini, Antonio
Venue
International Journal of Endocrinology
Publisher
Wiley
Published
2020-01-21
Volume
2020
Pages
1-9
ISSN
  • 1687-8337 (ISSN-L)
  • 1687-8345
OpenAlex
W3001691037
Cited by
14
References
68
Citations by year
2025: 2 · 2024: 2 · 2023: 2 · 2022: 4 · 2021: 1 · 2020: 3
FWCI
0.42
Type
journal article
Language
en
Open access
Locations
  • International Journal of Endocrinology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • CINECA IRIS Institutional Research Information System (University of Bari Aldo Moro) (submittedVersion, other-oa)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
  • Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
Keywords
male hypogonadism, selective estrogen receptor modulators, selective androgen receptor modulators, aromatase inhibitors, testosterone replacement therapy, androgen receptor, hypothalamic-pituitary-testicular axis, obesity, chronic inflammatory diseases, gonadotropin secretion, anabolic effects

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Is There Room for SERMs or SARMs as Alternative Therapies for Adult Male Hypogonadism? https://app.cochat.ai/papers/10.1155/2020/9649838
The paper
Giagulli, V. A., Silvestrini, A., Bruno, C., Triggiani, V., Mordente, A., & Mancini, A. (2020). Is There Room for SERMs or SARMs as Alternative Therapies for Adult Male Hypogonadism? International Journal of Endocrinology. https://doi.org/10.1155/2020/9649838

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.